Dr. Jessica Lenore Pierce, MD

Dr. Pierce practices at Renal Associates, P.A. in San Antonio, Texas.

Dr. Pierce's NPI, 1831120344, was assigned on July 5, 2006. Dr. Pierce graduated from Joe R. & Teresa Lozano Long School of Medicine in 2001. Dr. Pierce's Texas license number on file is M2751.

Dr. Pierce's primary practice is Renal Associates, P.A., at 4458 Medical Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 614-1231.

Dr. Pierce's primary practice is Renal Associates, P.A. in San Antonio, Texas. Dr. Pierce is also affiliated with University Hospital. The medical group on file is Renal Associates. Dmand AI also links Dr. Pierce to 3 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pierce practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Pierce's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Pierce is board certified in nephrology by the American Board of Internal Medicine. Dr. Pierce has a license on file in Texas.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Pierce treats.

CMS data shows 2,744 Medicare services from Dr. Pierce across 21 procedure codes in 2024, for 454 Medicare patients. Medicare paid $172,841 for them.

CMS counts 454 Medicare patients who saw Dr. Pierce in 2024. The largest group is under 65, with 148 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 5.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pierce's median patient age at 65, with 47% women.

In 2024, Dr. Pierce wrote 2,271 Medicare Part D claims for 245 patients. 86% of them were for generic drugs. CMS names the drug for 1,896 of them, across 51 drugs with 11 or more claims each, at $282,654 in total drug cost. In 2023, CMS named 1,716 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Pierce for performance year 2024, reported as part of a group. Dr. Pierce accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pierce as offering telehealth.

Dmand AI links 2 papers to Dr. Pierce. Dr. Pierce's most frequent co-author is Anthony J. Infante, MD.

CMS Open Payments shows 233 general payments to Dr. Pierce from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $790.

Dmand AI lists 1 award for Dr. Pierce, most recently CMS Stage 1 EHR in 2012.

Dr. Pierce graduated from Joe R. & Teresa Lozano Long School of Medicine in 2001.

Dr. Pierce is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.